Published in Cancer Weekly, June 20th, 2000
V.B. Pai and a colleague from Ohio State University in Columbus, Ohio, discussed the implications of anthracycline cytostatic antibiotics and alkylating agents on the cardiovascular system. Some of the most common chemotherapy treatments, they stated, result in cardiotoxicity. Doxorubicin, danurubicin, and fluorouracil, for instance, may create cardiotoxicity in more than 20% of treated patients. Cardiac complications that may occur at any time after treatment - hours, months, or even years...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.